<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03738176</url>
  </required_header>
  <id_info>
    <org_study_id>2:5:1</org_study_id>
    <nct_id>NCT03738176</nct_id>
  </id_info>
  <brief_title>The Efficacy of Topical Sesame Oil Versus Topical Triamcinolone on Oral Lichen Planus and Salivary Level of Oxidative Stress Biomarker [MDA]</brief_title>
  <acronym>(MDA)</acronym>
  <official_title>The Efficacy of Topical Sesame Oil in Orabase Versus Topical Triamcinolone in Orabase on Oral Lichen Planus and Salivary Level of Oxidative Stress Biomarker, Malondialdehyde [MDA] : Randomized Clinical Trial (RCT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mona Taha Mohammed MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      use seseme oil and corticosteroid topically for two groups
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  The enrolled patients will be divided randomly into two groups.

        -  Test group will receive topical sesame oil (3 times /day after eating) for a month.

        -  Control group will receive topical corticosteroid (3 times /day after eating) for a
           month.

        -  Assessment of the appearance score and severity of pain as well as the clinical
           parameter outcome will be done at baseline and at the end of two and four weeks and will
           be recorded in the patients' questionnaires &amp; by clinical sign score . MDA will be
           measured at the baseline &amp; at the end of four weeks after treatment.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 16, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 16, 2020</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>sesame oil in orabase(80 gm CMC -20 gm sesame oil)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain intensit measure</measure>
    <time_frame>4 weeks</time_frame>
    <description>measured by visual analogue scale where0 no pain and 10 sever pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>reduction of clinical signs measure</measure>
    <time_frame>4 weeks</time_frame>
    <description>Thongprasom Score 5 = white striae with erosive area = 1 cm2 Score 4 = white striae with erosive area &lt; 1 cm2 Score 3 = white striae with erosive area &gt; 1 cm2 Score 2 = white striae with atrophic area &lt; 1 cm2 Score 1 = mild white striae only Score 0 = no lesion normal</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Salivary level of oxidative stress biomarker (MDA)</measure>
    <time_frame>4 weeks</time_frame>
    <description>measured by reaction with thiobarbituric acid (TBA)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Oral Lichen Planus</condition>
  <arm_group>
    <arm_group_label>sesame oil in orabase</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 gm sesame oil-80 gm CMC 3 times per day for one month</description>
  </arm_group>
  <arm_group>
    <arm_group_label>triamcinolone in orabase</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>140 gm triamcinolone-50 gm Na CMC 3 times per day for one month</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sesame Oil</intervention_name>
    <description>Sesame oil(80 gm NaCMC-20 gmSesame oil)</description>
    <arm_group_label>sesame oil in orabase</arm_group_label>
    <other_name>sesame oil gel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>triamcinolone in orabase</intervention_name>
    <description>triamcinolone 140 gm-Na CMC 50 gm</description>
    <arm_group_label>triamcinolone in orabase</arm_group_label>
    <other_name>kenacorte</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who will be clinically diagnosed as having atrophic &amp;/or erosive oral lichen
             planus.

               -  Patients with no history of taking topical corticosteroids for the last 2 months
                  and systemic corticosteroid for the last 6 months

               -  Patients who agree to take medication and follow up .

        Exclusion Criteria:

          -  Pregnant and lactating ladies.

               -  Patients with history of topical steroids during last 2 months &amp; systemic
                  steroids during last 6 months.

               -  Patients with recent dental filling associated with the lesion or associated with
                  recent drug administration.

               -  Patient with history of diabetes or hypertension or those with positive HCV ab or
                  HBs Ag.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mona Taha Mohammed Ahammed, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo U</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mona Taha Mohammed Ahamed, Master</last_name>
    <phone>01123294474</phone>
    <email>mona.taha@dentistry.cu.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amal ALI Ali, LEcturer</last_name>
    <phone>01156520918</phone>
    <email>amal.ali@dentistry.cu.edu.eg</email>
  </overall_contact_backup>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 8, 2018</study_first_submitted>
  <study_first_submitted_qc>November 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2018</study_first_posted>
  <last_update_submitted>August 1, 2019</last_update_submitted>
  <last_update_submitted_qc>August 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mona Taha Mohammed MD</investigator_full_name>
    <investigator_title>clinical researcher</investigator_title>
  </responsible_party>
  <keyword>Oral lichen planus</keyword>
  <keyword>sesame oil</keyword>
  <keyword>corticosteroid</keyword>
  <keyword>MDA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lichen Planus, Oral</mesh_term>
    <mesh_term>Lichen Planus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triamcinolone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

